Blair Lucas - TBG Diagnostics Insider

PGL -- Australia Stock  

AUD 0.16  0.00  0.00%

  Executive
Mr. Blair Lucas was Company Secretary of Progen Pharmaceuticals Ltd since August 21 2012
  Executive Since 2012      
61 7 3273 9133  http://www.tbgbio.com
Lucas serves as Company Secretary and inhouse counsel for a number of private and public companies in both China and Australia. He has knowledge of Australian corporate regulatory environment and practical experience in China, including various capital raisings, crossborder transactions, and corporate and commercial law. He holds Master of Law, a Bachelor of Arts in Chinese and is a Member of Chartered Secretaries Australia.

Management Efficiency

The company has return on total asset (ROA) of (47.62) % which means that it has lost $47.62 on every $100 spent on asset. This is way below average.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Tim PaineRio Tinto Limited
2013
Gerard FlorianAustralia and New Zealand Banki
N/A
John PriestleyAustralia and New Zealand Banki
2017
Joanne FarrellRio Tinto Limited
2016
David BComWestpac Banking Corporation
N/A
Tim BultWesfarmers Limited
2015
Warren BaillieWoodside Petroleum Ltd
2012
Christine ParkerWestpac Banking Corporation
2011
Tara DinesBHP Billiton Limited
N/A
Alfredo BarriosRio Tinto Limited
2014
Vittoria ShorttCommonwealth Bank of Australia
2015
Tony AdamsTransurban Group
2014
Alan CarpenterWesfarmers Limited
2009
Paul MeadowsWesfarmers Limited
2010
Taryn MortonCommonwealth Bank of Australia
2015
Kara NichollsWoolworths Group Limited
2015
Anna LenahanCommonwealth Bank of Australia
2016
Jill CraigAustralia and New Zealand Banki
N/A
Fiona MeadCSL Limited
2018
John HuntWoolworths Group Limited
2016
David OvingtonRio Tinto Limited
2017

Entity Summary

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.

TBG Diagnostics Limited Leadership Team

Fleur Lankesheer, Director - Business Development and Legal
Keith Dredge, Director of Drug Development
Leslie Tillack, CEO - Pharmasynth
YuZen Cheng, Director
ChiaChuan Chang, Non-Executive Director
Lee Horobin, General Manager of Fin.
ShiChung Chang, Director
Indrajit Arulampalam, Executive Chairman
Blair Lucas, Company Secretary
Emily Lee, Director

Stock Performance Indicators

Current Sentiment - PGL

TBG Diagnostics Limited Investor Sentiment
Macroaxis portfolio users are evenly split in their perspective on investing in TBG Diagnostics Limited. What is your outlook on investing in TBG Diagnostics Limited? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
MSFT   
Purchased over 20 shares of
2 days ago
Traded for 106.27
F   
Purchased over 200 shares of
2 days ago
Traded for 10.56
GM   
Purchased over 70 shares of
2 days ago
Traded for 39.4
GOOG   
Purchased few shares of
2 days ago
Traded for 1184.91
C   
Purchased over 40 shares of
2 days ago
Traded for 69.22
Additionally take a look at Your Equity Center. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">